Application Note

Reducing The Bioburden Load In Drug Formulation And Filling

By Critical Process Filtration

Debunking Regulatory Myths In CGT Orphan Drug Development

Controlling bioburden in downstream biopharmaceutical processes is essential for maintaining product quality and protecting critical filtration steps. While sterilizing filters serve as the final safeguard, their effectiveness depends heavily on upstream filtration working efficiently to reduce microbial load. Without proper prefiltration, excess microorganisms — introduced through process streams, materials, or the production environment — can foul sterilizing filters, disrupt batch operations, and increase costs.

A well-designed filtration strategy targets contaminants at multiple stages, removing larger organisms such as molds and yeasts with depth filters, followed by membrane filtration to reduce bacterial levels. Selecting the right filter media and pore size—based on organism size, concentration, and product sensitivity — is key to balancing performance and yield.

Layered bioburden control strengthens filtration performance by reducing fouling, improving reliability, and extending filter life. Gain practical insight into optimizing downstream processes and maintaining consistent product quality in complex manufacturing environments.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online